Project Grant K01AT013764
- The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health awarded The General Hospital Corporation, doing business as Massachusetts General Hospital, $170,640 on April 17, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds development and feasibility testing of TOPMED (Toolkit for Optimal Pain Management in the Emergency Department), a mind-body intervention designed to reduce pain...
- The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $1.46M Project Grant under the Mental Health Research Grants program (CFDA 93.242) on September 15, 2025, to develop and implement a novel therapeutic intervention combining real-time functional magnetic resonance imaging (fMRI) neurofeedback with mindfulness-based training to address repetitive negative thinking (RNT) in adolescents at risk for serious mental illness. The 24-month project will deliver a...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Beth Israel Deaconess Medical Center, Inc. (BIDMC) $637,845 on June 19, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a remote, randomized controlled study assessing the efficacy of mindfulness apps for people with depression using precision medicine methodology. The research compares participants randomized to...
- The National Center for Complementary and Integrative Health awarded Massachusetts General Hospital (operating as The General Hospital Corporation) a Cooperative Agreement totaling $1,258,356 on August 5, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). Performance runs through July 31, 2027, with work performed in Boston, Massachusetts. The award funds the Toolkit for Optimal Recovery After Orthopedic Injury (TOR), a multi-site efficacy...
- This Project Grant award of $125,026 from the National Center for Complementary and Integrative Health (CFDA 93.213 - Research and Training in Complementary and Integrative Health) will fund research conducted by the Massachusetts Institute of Technology (MIT) to investigate the brain bases of mindfulness. The project aims to: 1) identify reliable brain network connections that predict trait mindfulness using resting-state fMRI data from over 350 adults, and 2) examine state mindfulness and...
- The National Center for Complementary and Integrative Health (part of the Department of Health and Human Services National Institutes of Health) awarded $164,268 to the University of Washington on April 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to optimize mindfulness-based cognitive therapy practice for chronic pain in people with multiple sclerosis. The award funds a K23 career development project running through March 31, 2031,...
- The National Center for Complementary and Integrative Health, within the Department of Health and Human Services National Institutes of Health, awarded Yale University $634,664 on August 28, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a multi-site feasibility trial of smartphone-based mindfulness treatment for promoting addiction recovery. The award funds development and testing of a digital mindfulness-based treatment designed...
- The National Institute of Mental Health awarded Massachusetts General Hospital $453,750 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a closed-loop system for assessing target network engagement using concurrent transcranial magnetic stimulation and functional MRI. The recipient is developing a flexible radiofrequency coil array (the RF Cap) that enables functional MRI acquisition simultaneously with transcranial magnetic stimulation in a...
- This Project Grant award of $750,079 from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) aims to develop and pilot test a combined "SMART-QTC" intervention for Asian American patients with co-occurring major depressive disorder and distressing somatic symptoms. The grantee, The General Hospital Corporation (doing business as Massachusetts General Hospital), will...
- The National Institute of Mental Health awarded The General Hospital Corporation (Massachusetts General Hospital) $790,560 under the Mental Health Research Grants program (CFDA 93.242) on April 1, 2026. The award funds development of advanced artificial intelligence models to predict differential antidepressant treatment responses by integrating electronic health records and genomic data. Aim 1 involves building a large language model-based, human-in-the-loop active learning framework to...
The National Center for Complementary and Integrative Health (NCCIH), part of the Department of Health and Human Services National Institutes of Health, awarded $133,236 to Massachusetts General Hospital on August 4, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to develop and validate a tailored digital mindfulness intervention for emerging adults experiencing problematic social media use and anxiety symptoms. The award funds development of the Healthy Minds Program for Emerging Adults (HMP-EA), which tailors existing mindfulness-training modules to address the specific needs and preferences of emerging adults with problematic social media use. The intervention integrates just-in-time technology to deliver nudges toward mindfulness practices during periods of social media use, designed to interrupt maladaptive behaviors and reduce anxiety symptoms and rumination. The program consists of educational and guided mindfulness practice modules delivered through a mobile application. Massachusetts General Hospital's Research Management Division, operating from Boston, Massachusetts, is the recipient. The project runs from the award date through July 31, 2031. Work is performed at MGH's Research Management Division in Boston, MA 02114.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $133.2k | 8/6/26 |